Author + information
- Received June 28, 1994
- Revision received August 9, 1995
- Accepted August 25, 1995
- Published online January 1, 1996.
- Joseph R. Hartmann, MD, FACCa,**,
- Louis S. McKeever, MD, FACCa,
- William W. O'Neill, MD, FACC*,
- Christopher J. White, MD, FACC†,
- Patrick L. Whitlow, MD, FACC‡,
- Paul S. Gilmore, MD, FACC§,
- Andrew J. Doorey, MD, FACC¶,
- Joseph P. Galichia, MD, FACC∥ and
- Elaine L. Enger, MSa
- ↵**Address for correspondence: Dr. Joseph R. Hartmann, Midwest Heart Research Foundation, 2340 Highland Avenue, Suite 310, Lombard, Illinois 60148.
Objectives. This multicenter study sought to evaluate the shortterm efficacy and safety of prolonged, low dose, direct urokinase infusion in recanalization of chronically occluded saphenous vein bypass grafts in a large sample of patients, as well as to determine the 6-month patency rates for this procedure.
Background. Patients with chronically occluded aortocoronary vein grafts and uncontrolled angina pectoris have limited options for therapy. Previous work has shown that chronically occluded vein grafts can be recanalized by thrombolysis.
Methods. A coaxial infusion of urokinase (100,000 U/h) was given directly into occluded vein grafts in 107 patients. Balloon angioplasty was performed after lysis was achieved. Patients were discharged with warfarin and aspirin therapy. Six-month clinical follow-up data were obtained, and repeat angiography was encouraged.
Results. Initial patency was achieved in 74 patients (69%). Mean duration of infusion was 25.4 h, and mean urokinase dosage was 3.70 million U. Acute adverse events included acute myocardial infarction in 5 patients (5%), enzyme level elevation in 18 (17%), emergency coronary artery bypass graft surgery in 4 (4%), stroke in 3 (3%) and death in 7 (6.5%). Recanalization was unsuccessful in all seven patients who died. Six-month follow-up angiograms were obtained for 40 patients (54%), 16 of whom maintained a patent graft (40%). Angina was present in 13 patients with successful (22%) and 12 with unsuccessful (71%) recanalization at 6-month follow-up.
Conclusions. Chronically occluded aortocoronary vein grafts can be recanalized in ∼70% of appropriately selected patients. Complications are similar to those observed with repeat operations. Clinical follow-up shows an improvement in angina. This procedure is intended for patients with only one occluded vein graft. Strict adherence to the protocol will improve patency and reduce complications.
This study was financially supported by Abbott Laboratories Hemodynamic Venture, Abbott Park, Illinois.
- Received June 28, 1994.
- Revision received August 9, 1995.
- Accepted August 25, 1995.
- American College of Cardiology